The Lupus Academy podcast

REGENCY: Obinutuzumab’s Promise for Lupus Nephritis

0:00
53:48
Recuar 15 segundos
Avançar 15 segundos

Join Dr Raquel Faria and Professors Richard Furie and Maria Dall’Era as they discuss the results of the phase 3 REGENCY trial of obinutuzumab for the treatment of lupus nephritis.This episode explores what obinutuzumab could mean for the future management of lupus nephritis.

Disclaimer: During Lupus Academy podcast episodes, participants may refer to off label use of medicines forpatients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.

Mais episódios de "The Lupus Academy"